MENU
+Compare
EYPT
Stock ticker: NASDAQ
AS OF
Jul 10, 12:53 PM (EDT)
Price
$10.97
Change
+$0.01 (+0.09%)
Capitalization
754.18M

EYPT EyePoint Pharmaceuticals Forecast, Technical & Fundamental Analysis

EyePoint Pharmaceuticals Inc is a pharmaceutical company... Show more

EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EYPT with price predictions
Jul 09, 2025

Momentum Indicator for EYPT turns positive, indicating new upward trend

EYPT saw its Momentum Indicator move above the 0 level on June 24, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator turned positive. In of the 72 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EYPT just turned positive on July 09, 2025. Looking at past instances where EYPT's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EYPT advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 165 cases where EYPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where EYPT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EYPT broke above its upper Bollinger Band on June 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EYPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.527) is normal, around the industry mean (17.327). P/E Ratio (0.000) is within average values for comparable stocks, (59.374). EYPT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.418). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (11.834) is also within normal values, averaging (272.335).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EYPT is expected to report earnings to rise 23.92% to -80 cents per share on July 30

EyePoint Pharmaceuticals EYPT Stock Earnings Reports
Q2'25
Est.
$-0.81
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.14
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
The last earnings report on May 07 showed earnings per share of -64 cents, beating the estimate of -67 cents. With 82.52K shares outstanding, the current market capitalization sits at 754.18M.
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 617 926-5000
Employees
121
Web
https://www.eyepointpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NQVRX58.84N/A
N/A
Nuveen Multi Cap Value I
HAGIX82.59N/A
N/A
Carillon Eagle Mid Cap Growth I
CLEYX21.55N/A
N/A
Columbia Select Large Cap Equity Inst3
TLACX11.72N/A
N/A
Transamerica Large Core ESG A
CGLIX18.05N/A
N/A
Calvert Global Equity Fund Class I

EYPT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+10.15%
OCUL - EYPT
59%
Loosely correlated
+8.47%
LYRA - EYPT
58%
Loosely correlated
+0.54%
RXRX - EYPT
55%
Loosely correlated
+4.29%
CRSP - EYPT
54%
Loosely correlated
+9.60%
ATHE - EYPT
54%
Loosely correlated
-4.87%
More